ISIN | LU1540960942 |
---|---|
Valor Number | 35006892 |
Bloomberg Global ID | |
Fund Name | HBM Global Healthcare Fund A USD Cap |
Fund Provider |
HBM Partners AG
Zug, Schweiz Phone: +41 43 888 71 71 E-Mail: investorrelations@hbmpartners.com Web: www.hbmpartners.com |
Fund Provider | HBM Partners AG |
Representative in Switzerland |
FundPartner Solutions (Suisse) SA Genève 75 |
Distributor(s) | FundPartner Solutions (Suisse) S.A. |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the Sub-Fund is to achieve long-term capital gains, by pursuing a long/short strategy in the "healthcare" market. The goal is to generate a value trend that exceeds the performance of the SOFR (the “Benchmark”). No guarantee can be given that the investment objective will be achieved. |
Peculiarities |
Current Price * | 275.51 USD | 02.10.2024 |
---|---|---|
Previous Price * | 276.38 USD | 01.10.2024 |
52 Week High * | 287.82 USD | 16.09.2024 |
52 Week Low * | 207.29 USD | 27.10.2023 |
NAV * | 275.51 USD | 02.10.2024 |
Issue Price * | 275.51 USD | 02.10.2024 |
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 19,383,232 | |
Unit/Share Assets *** | 2,195,653 | |
Trading Information SIX |
YTD Performance | +12.55% |
29.12.2023 - 02.10.2024
29.12.2023 02.10.2024 |
---|---|---|
YTD Performance (in CHF) | +13.64% |
29.12.2023 - 02.10.2024
29.12.2023 02.10.2024 |
1 month | -4.10% |
02.09.2024 - 02.10.2024
02.09.2024 02.10.2024 |
3 months | +3.72% |
02.07.2024 - 02.10.2024
02.07.2024 02.10.2024 |
6 months | +2.21% |
02.04.2024 - 02.10.2024
02.04.2024 02.10.2024 |
1 year | +26.53% |
02.10.2023 - 02.10.2024
02.10.2023 02.10.2024 |
2 years | +25.04% |
05.10.2022 - 02.10.2024
05.10.2022 02.10.2024 |
3 years | +5.50% |
06.10.2021 - 02.10.2024
06.10.2021 02.10.2024 |
5 years | +53.10% |
02.10.2019 - 02.10.2024
02.10.2019 02.10.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 9.56% | |
---|---|---|
Novo Nordisk A/S Class B | 6.58% | |
UnitedHealth Group Inc | 6.51% | |
McKesson Corp | 5.84% | |
AbbVie Inc | 4.76% | |
Stryker Corp | 4.73% | |
DexCom Inc | 3.46% | |
UCB SA | 3.30% | |
The Cooper Companies Inc | 3.30% | |
Exact Sciences Corp | 3.29% | |
Last data update | 30.06.2024 |
TER | 0.0215% |
---|---|
TER date | 31.01.2018 |
Performance Fee *** | 15.00% |
PTR | |
Max. Management Fee *** | 1.60% |
Ongoing Charges *** | 2.18% |
SRRI ***
|
|
SRRI date *** | 30.09.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |